Opening the Course to Price Transparency by Closing the Safe Harbor on Part D Drug Rebates

The Centers for Medicare & Medicaid Services (CMS) is about to publish a proposed rule that – according to the Health and Human Services Department (HHS) – would lower prescription drug prices and out-of-pocket costs for patients and increase pricing transparency. The HHS proposal would eliminate a safe harbor for prescription drug rebates that drug […]

Read More

Now in the Consumer-Centric Healthcare Spotlight: Microsoft & Walgreens

We’ve been steadily predicting the formation of many unusual partnerships as the healthcare industry shifts toward consumer-centric healthcare business models. And our forecasts keep coming to pass: Think of CVS-Aetna, Cigna and Express Scripts and, of course, Amazon’s venture with JP Morgan Chase and Berkshire Hathaway. Now we can add Walgreens Boots Alliance and Microsoft to the list. […]

Read More